18 results on '"Steven P. Rowe"'
Search Results
2. Incidental primary breast cancer detected on surveillance 68Ga-DOTATATE PET/CT in a patient with metastatic neuroendocrine carcinoma
- Author
-
Emily B. Ambinder, MD, Rudolf A. Werner, MD, and Steven P. Rowe, MD, PhD
- Subjects
Breast neoplasm ,Dotatate PET/CT ,Somatostatin receptor imaging ,Neuroendocrine carcinoma ,Medical physics. Medical radiology. Nuclear medicine ,R895-920 - Abstract
We present a case of a 53-year-old woman with metastatic neuroendocrine tumor, presumed primary in the small intestine with metastases to the liver and mesenteric lymph nodes. The patient was being treated with lanreotide and followed with somatostatin receptor (SSTR)-targeted 68Ga-labeled 1,4,7,10-tetraazacyclododecane-N,N', N'',N'''-tetraacetic acid-d-Phe(1)-Tyr(3)-octreotate (68Ga-DOTATATE) positron emission tomography – computed tomography (PET/CT). On a follow-up exam, the patient's primary and metastatic disease had improved but she had new 68Ga-DOTATATE-avid lesions in the right breast and right axilla. Subsequent breast imaging workup and biopsy demonstrated a primary breast cancer and axillary lymph node metastasis.
- Published
- 2020
- Full Text
- View/download PDF
3. Online Prostate-Specific Membrane Antigen and Positron Emission Tomography–Guided Radiation Therapy for Oligometastatic Prostate Cancer
- Author
-
William T. Hrinivich, PhD, Ryan Phillips, MD, PhD, Angela J. Da Silva, PhD, Noura Radwan, MD, Michael A. Gorin, MD, Steven P. Rowe, MD, PhD, Kenneth J. Pienta, MD, Martin G. Pomper, MD, PhD, John Wong, PhD, Phuoc T. Tran, MD, PhD, and Ken Kang-Hsin Wang, PhD
- Subjects
Medical physics. Medical radiology. Nuclear medicine ,R895-920 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Purpose: Stereotactic ablative radiation therapy (SABR) for oligometastatic prostate cancer (OMPC) may improve clinical outcomes, but current challenges in intrafraction tracking of multiple small targets limits treatment accuracy. A biology-guided radiation therapy (BgRT) delivery system incorporating positron emission tomography (PET) detectors is being developed to use radiotracer uptake as a biologic fiducial for intrafraction tumor tracking to improve geometric accuracy. This study simulates prostate-specific membrane antigen (PSMA)-directed BgRT using a cohort from our phase II randomized trial of SABR in men with recurrent hormone sensitive OMPC and compares dose distributions to clinical SABR (CSABR). Methods and Materials: A research treatment planning system (RTPS) was used to replan 15 patients imaged with PSMA-targeted 18F-DCFPyL PET/computed tomography and previously treated with CSABR using conventional linear accelerators (linacs). The RTPS models a prototype ring-mounted linac incorporating PET and kilo-voltage computed tomography imaging subsystems and can be used to optimize BgRT plans, as well as research SABR (RSABR) plans, which use the prototype linac without radiotracer guidance. CSABR, RSABR, and BgRT plans were compared in terms of maximum planning target volume (PTV) dose (Dmax), mean dose to proximal organs at risk (DOAR), conformity index, as well as voxel-wise correlation of dose with PET specific uptake values to investigate possible dose-painting effects. Results: RSABR and BgRT plans resulted in mean ± standard deviation increases in Dmax of 4 ± 11% (P = .21) and 18 ± 15% (P < .001) and reductions in DOAR of –20 ± 19% (P
- Published
- 2020
- Full Text
- View/download PDF
4. Diagnosing small bowel carcinoid tumor in a patient with oligometastatic prostate cancer imaged with PSMA-Targeted [18F]DCFPyL PET/CT: Value of the PSMA-RADS-3D Designation
- Author
-
Eugene Shenderov, Michael A. Gorin, Seohyun Kim, Pamela T. Johnson, Mohamad E. Allaf, Alan W. Partin, Martin G. Pomper, Emmanuel S. Antonarakis, Kenneth J. Pienta, and Steven P. Rowe
- Subjects
Prostate cancer ,PSMA ,Carcinoid ,Diseases of the genitourinary system. Urology ,RC870-923 - Abstract
Radiotracers targeting prostate-specific membrane antigen (PSMA), including [18F]DCFPyL, have been extensively investigated as a means to image prostate cancer more accurately. We present the case of a man with oligometastatic prostate cancer who was also diagnosed with a metastatic small bowel carcinoid tumor following the detection of indeterminate findings on a [18F]DCFPyL PET and discuss how this case highlights the utility of a newly proposed reporting system for PSMA-targeted PET (PSMA-RADS version 1.0).
- Published
- 2018
- Full Text
- View/download PDF
5. PSMA-targeted [18F]DCFPyL PET/CT-avid lesions in a patient with prostate cancer: Clinical decision-making informed by the PSMA-RADS interpretive framework
- Author
-
Diane K. Reyes, Shadpour Demehri, Rudolf A. Werner, Martin G. Pomper, Michael A. Gorin, Steven P. Rowe, and Kenneth J. Pienta
- Subjects
Diseases of the genitourinary system. Urology ,RC870-923 - Abstract
We present the case of a man with oligometastatic prostate cancer who underwent a PSMA-targeted 18F-DCFPyL PET/CT scan in order to illustrate how the PSMA-RADS grading sytem can be successfully used to support clinical decision-making and treatment planning. Notably, the presented patient was found to have an equivocal bone lesion (PSMA-RADS-3B) which was further worked up with a tumor protocol MRI and found to be definitively benign (PSMA-RADS-1B) and thus removed from the oligometastatic treatment plan. Remaining avid lesions were incorporated into the treatment plan or deferred for later work-up or monitoring, as indicated within the PSMA-RADS framework. Keywords: PSMA, DCFPyL, Prostate cancer, Oligometastatic
- Published
- 2019
- Full Text
- View/download PDF
6. Fetal and placental anatomy visualized with cinematic rendering from volumetric CT data
- Author
-
Steven P. Rowe, MD, PhD and Elliot K. Fishman, MD
- Subjects
Cinematic rendering ,Fetal anatomy ,3D CT ,Medical physics. Medical radiology. Nuclear medicine ,R895-920 - Abstract
Avoiding unnecessary radiation exposure in children, including fetuses or embryos, is of paramount importance. However, emergent clinical situations will arise that necessitate the use of ionizing radiation-based modalities, such as computed tomography (CT), in this patient population. In such circumstances, the use of advanced visualization methods may provide optimum diagnostic utility. We present the case of a pregnant patient with Loeys-Dietz syndrome who was evaluated with CT angiography to rule out an acute aortic syndrome. The CT data from the fetus and placenta were reconstructed using the new cinematic rendering technique that allows for photorealistic display. The potential advantages of cinematic rendering relative to traditional volume rendering are discussed.
- Published
- 2018
- Full Text
- View/download PDF
7. Complete biochemical response after stereotactic ablative radiotherapy of an isolated prostate cancer pelvic soft tissue recurrence detected by 18F-DCFPyL PET/CT
- Author
-
Ryan M. Phillips, Michael A. Gorin, Steven P. Rowe, Martin G. Pomper, Kenneth J. Pienta, Ashley E. Ross, and Phuoc T. Tran
- Subjects
Prostate cancer ,Local recurrence ,PSMA ,Molecular imaging ,Radiotherapy ,Diseases of the genitourinary system. Urology ,RC870-923 - Published
- 2018
- Full Text
- View/download PDF
8. Renal Pseudoaneurysm Mimicking Local Cancer Recurrence After Partial Nephrectomy
- Author
-
Scott P. Campbell, Steven P. Rowe, Michael A. Gorin, and Mohamad E. Allaf
- Subjects
Renal pseudoaneurysm ,Partial nephrectomy ,Arteriovenous fistula ,AV fistula ,Renal AV abnormality ,Diseases of the genitourinary system. Urology ,RC870-923 - Abstract
The development of an iatrogenic vascular lesion, such a renal pseudoaneurysm or arteriovenous fistula, is a rare complication of partial nephrectomy. These lesions should be considered in patients presenting with an enhancing mass in the resection bed shortly following partial nephrectomy. Early timing following surgery, large relative size, and the presence of recurrent hematuria suggest the diagnosis of an iatrogenic vascular lesion. Duplex ultrasound is a useful non-invasive imaging modality for differentiating these lesions from a local tumor recurrence.
- Published
- 2017
- Full Text
- View/download PDF
9. Acute axillary lymphadenopathy detected shortly after COVID-19 vaccination found to be due to newly diagnosed metastatic melanoma
- Author
-
David M Gullotti, Evan J Lipson, Elliot K Fishman, and Steven P Rowe
- Subjects
Medical physics. Medical radiology. Nuclear medicine ,PET/CT ,SARS-CoV2 ,R895-920 ,COVID-19 ,Lymphadenopathy ,Case Report ,Radiology, Nuclear Medicine and imaging ,COVID-19 vaccine - Abstract
As the administration of COVID-19 vaccines continues to increase, so too does awareness of the associated ipsilateral axillary lymphadenopathy. This has created a diagnostic challenge in the field of radiology, in particular among patients with cancer, as post-vaccination reactive adenopathy has been reported to be mistakenly interpreted as malignancy. As radiology departments improve their protocols for obtaining vaccine-related patient history, and radiologists become acclimated to attributing axillary lymphadenopathy to recent COVID-19 vaccination, there is a risk of the pendulum swinging too far and under-diagnosing true oncologic disease. This report describes an otherwise healthy 53-year-old man who presented with discomfort due to ipsilateral axillary lymphadenopathy shortly after receiving a COVID-19 vaccine. Fine needle aspiration performed within 2 months of receiving the vaccine revealed metastatic melanoma and subsequent 18F-FDG PET/CT demonstrated intensely avid axillary and supraclavicular adenopathy without visualization of a primary lesion. This case serves as a cautionary report to remind clinicians to remain suspicious of possible underlying malignancy with the presence of axillary adenopathy, despite a history of recent COVID-19 vaccination.
- Published
- 2022
10. Online Prostate-Specific Membrane Antigen and Positron Emission Tomography–Guided Radiation Therapy for Oligometastatic Prostate Cancer
- Author
-
Ryan Phillips, William T. Hrinivich, Ken Kang Hsin Wang, Kenneth J. Pienta, Phuoc T. Tran, John Wong, Angela J. Da Silva, Martin G. Pomper, Steven P. Rowe, Michael A. Gorin, and Noura Radwan
- Subjects
lcsh:Medical physics. Medical radiology. Nuclear medicine ,medicine.medical_treatment ,lcsh:R895-920 ,SABR volatility model ,lcsh:RC254-282 ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,Prostate cancer ,0302 clinical medicine ,medicine ,Glutamate carboxypeptidase II ,Radiology, Nuclear Medicine and imaging ,Radiation treatment planning ,medicine.diagnostic_test ,business.industry ,medicine.disease ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Conformity index ,Radiation therapy ,Oncology ,Positron emission tomography ,030220 oncology & carcinogenesis ,Physics Contribution ,business ,Nuclear medicine ,Fiducial marker - Abstract
Purpose: Stereotactic ablative radiation therapy (SABR) for oligometastatic prostate cancer (OMPC) may improve clinical outcomes, but current challenges in intrafraction tracking of multiple small targets limits treatment accuracy. A biology-guided radiation therapy (BgRT) delivery system incorporating positron emission tomography (PET) detectors is being developed to use radiotracer uptake as a biologic fiducial for intrafraction tumor tracking to improve geometric accuracy. This study simulates prostate-specific membrane antigen (PSMA)-directed BgRT using a cohort from our phase II randomized trial of SABR in men with recurrent hormone sensitive OMPC and compares dose distributions to clinical SABR (CSABR). Methods and Materials: A research treatment planning system (RTPS) was used to replan 15 patients imaged with PSMA-targeted 18F-DCFPyL PET/computed tomography and previously treated with CSABR using conventional linear accelerators (linacs). The RTPS models a prototype ring-mounted linac incorporating PET and kilo-voltage computed tomography imaging subsystems and can be used to optimize BgRT plans, as well as research SABR (RSABR) plans, which use the prototype linac without radiotracer guidance. CSABR, RSABR, and BgRT plans were compared in terms of maximum planning target volume (PTV) dose (Dmax), mean dose to proximal organs at risk (DOAR), conformity index, as well as voxel-wise correlation of dose with PET specific uptake values to investigate possible dose-painting effects. Results: RSABR and BgRT plans resulted in mean ± standard deviation increases in Dmax of 4 ± 11% (P = .21) and 18 ± 15% (P < .001) and reductions in DOAR of –20 ± 19% (P
- Published
- 2019
11. Prostate Cancer Theranostics
- Author
-
Takahiro Higuchi, Lilja B. Solnes, Thorsten Derlin, Rudolf A. Werner, Martin G. Pomper, Mohammad Salehi Sadaghiani, and Steven P. Rowe
- Subjects
Oncology ,medicine.medical_specialty ,Disease detection ,business.industry ,Fda approval ,medicine.medical_treatment ,The Renaissance ,Disease ,Immunotherapy ,medicine.disease ,Prostate cancer ,Internal medicine ,medicine ,High incidence ,business ,Membrane antigen - Abstract
A theranostic can broadly be defined as an agent used for disease detection and therapy. Here we focus on imaging-based theranostics. While the concept has been in practice for over 80 years in the case of radioiodine, recent advances in the discovery of targeted, high-affinity scaffolds, the rediscovery of previously obscure radionuclides for therapy, improvements in chelation chemistry, and a deeper understanding of radiation dosimetry have contributed to a renaissance in the field. Also contributing is the lack of safe and effective therapy for metastatic disease, with chemotherapy or even immunotherapy often not particularly effective, as for metastatic castration–resistant prostate cancer which carries a 1-year survival of ~40% once within bone. The availability of small-molecule scaffolds that target the prostate-specific membrane antigen, once pharmacokinetically optimized and outfitted with particle-emitting radionuclides, has also helped to revitalize theranostics, in part because of the high incidence of mCRPC. Participation in this area has markedly increased recently, with industry becoming involved, leading to likely FDA approval of several such agents in the near-term. Nevertheless, further work is needed regarding prospective trials, which will define whether theranostics can substantially extend the lives of men suffering from mCRPC.
- Published
- 2021
12. Diagnosing small bowel carcinoid tumor in a patient with oligometastatic prostate cancer imaged with PSMA-Targeted [18F]DCFPyL PET/CT: Value of the PSMA-RADS-3D Designation
- Author
-
Mohamad E. Allaf, Kenneth J. Pienta, Pamela T. Johnson, Michael A. Gorin, Eugene Shenderov, Seohyun Kim, Martin G. Pomper, Emmanuel S. Antonarakis, Steven P. Rowe, and Alan W. Partin
- Subjects
18F-DCFPyL ,medicine.medical_specialty ,PET-CT ,Prostate cancer ,business.industry ,Urology ,medicine.disease ,lcsh:Diseases of the genitourinary system. Urology ,lcsh:RC870-923 ,urologic and male genital diseases ,Carcinoid ,Small Bowel Carcinoid Tumor ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,0302 clinical medicine ,Oncology ,030220 oncology & carcinogenesis ,PSMA ,Medicine ,Radiology ,business ,Reporting system ,Membrane antigen - Abstract
Radiotracers targeting prostate-specific membrane antigen (PSMA), including [18F]DCFPyL, have been extensively investigated as a means to image prostate cancer more accurately. We present the case of a man with oligometastatic prostate cancer who was also diagnosed with a metastatic small bowel carcinoid tumor following the detection of indeterminate findings on a [18F]DCFPyL PET and discuss how this case highlights the utility of a newly proposed reporting system for PSMA-targeted PET (PSMA-RADS version 1.0).
- Published
- 2017
13. Liposarcoma metastases to the small bowel presenting as fat-density intraluminal lesions
- Author
-
Pamela T. Johnson, Stephanie Coquia, Elliot K. Fishman, and Steven P. Rowe
- Subjects
medicine.medical_specialty ,Gastrointestinal bleeding ,Metastatic Liposarcoma ,Small bowel metastases ,Case Report ,Bowel perforation ,Liposarcoma ,Gastroenterology ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Intussusception (medical disorder) ,medicine ,Radiology, Nuclear Medicine and imaging ,Small bowel resection ,Unusual case ,business.industry ,digestive, oral, and skin physiology ,Sarcoma ,medicine.disease ,digestive system diseases ,030220 oncology & carcinogenesis ,Radiology ,business ,030217 neurology & neurosurgery - Abstract
Metastatic disease to the small bowel is rare; however, it is important to recognize that when it does occurs a variety of complications are possible including obstruction, gastrointestinal bleeding, intussusception, and bowel perforation. We present here an unusual case of small bowel metastases in a patient with known metastatic liposarcoma in which the lesions manifested as rapidly evolving fat-density masses that necessitated segmental small bowel resection. Careful scrutiny of the small bowel in oncology patients is necessary to guide appropriate treatment and avoid potential catastrophic complications from small bowel metastases.
- Published
- 2016
14. Longitudinal improvements in clinical and functional outcomes following initiation of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis
- Author
-
Kadambari Vijaykumar, Hui Min Leung, Amilcar Barrios, Justin Wade, Heather Y. Hathorne, David P. Nichols, Guillermo J. Tearney, Steven M. Rowe, and George M. Solomon
- Subjects
Cystic fibrosis ,Highly effective modulator therapies ,Micro-optical coherence tomography ,Mucociliary abnormalities ,Science (General) ,Q1-390 ,Social sciences (General) ,H1-99 - Abstract
Background: Use of elexacaftor/tezacaftor/ivacaftor (ETI) for treatment of cystic fibrosis (CF) has resulted in unprecedented clinical improvements necessitating development of outcome measures for monitoring disease course. Intranasal micro-optical coherence tomography (μOCT) has previously helped detect and characterize mucociliary abnormalities in patients with CF. This study was done to determine if μOCT can define the effects of ETI on nasal mucociliary clearance and monitor changes conferred to understand mechanistic effects of CFTR modulators beyond CFTR activation. Methods: 26 subjects, with at least 1 F508del mutation were recruited and followed at baseline (visit 1), +1 month (visit 2) and +6 months (visit 4) following initiation of ETI therapy. Clinical outcomes were computed at visits 1, 2 and 4. Intranasal μOCT imaging and functional metrics analysis including mucociliary transport rate (MCT) estimation were done at visits 1 and 2. Results: Percent predicted forced expiratory volume in 1 s (ppFEV1) showed a significant increase of +10.9 % at visit 2, which sustained at visit 4 (+10.6 %). Sweat chloride levels significantly decreased by −36.6 mmol/L and −41.3 mmol/L at visits 2 and 4, respectively. μOCT analysis revealed significant improvement in MCT rate (2.8 ± 1.5, visit 1 vs 4.0 ± 1.5 mm/min, visit 2; P = 0.048). Conclusions: Treatment with ETI resulted in significant and sustained clinical improvements over 6 months. Functional improvements in MCT rate were evident within a month after initiation of ETI therapy indicating that μOCT imaging is sensitive to the treatment effect of HEMT and suggests improved mucociliary transport as a probable mechanism of action underlying the clinical benefits.
- Published
- 2024
- Full Text
- View/download PDF
15. Korean Red Ginseng aqueous extract improves markers of mucociliary clearance by stimulating chloride secretion
- Author
-
Do-Yeon Cho, Daniel Skinner, Shaoyan Zhang, Ahmed Lazrak, Dong Jin Lim, Christopher G. Weeks, Catherine G. Banks, Chang Kyun Han, Si-Kwan Kim, Guillermo J. Tearney, Sadis Matalon, Steven M. Rowe, and Bradford A. Woodworth
- Subjects
CFTR ,Chloride channels ,Mucociliary clearance ,Red Ginseng ,Sinusitis ,Botany ,QK1-989 - Abstract
Background: Abnormal chloride (Cl−) transport has a detrimental impact on mucociliary clearance in both cystic fibrosis (CF) and non-CF chronic rhinosinusitis. Ginseng is a medicinal plant noted to have anti-inflammatory and antimicrobial properties. The present study aims to assess the capability of red ginseng aqueous extract (RGAE) to promote transepithelial Cl− secretion in nasal epithelium. Methods: Primary murine nasal septal epithelial (MNSE) [wild-type (WT) and transgenic CFTR−/−], fisher-rat-thyroid (FRT) cells expressing human WT CFTR, and TMEM16A-expressing human embryonic kidney cultures were utilized for the present experiments. Ciliary beat frequency (CBF) and airway surface liquid (ASL) depth measurements were performed using micro–optical coherence tomography (μOCT). Mechanisms underlying transepithelial Cl− transport were determined using pharmacologic manipulation in Ussing chambers and whole-cell patch clamp analysis. Results: RGAE (at 30μg/mL of ginsenosides) significantly increased Cl− transport [measured as change in short-circuit current (ΔISC = μA/cm2)] when compared with control in WT and CFTR−/− MNSE (WT vs control = 49.8±2.6 vs 0.1+/−0.2, CFTR−/- = 33.5±1.5 vs 0.2±0.3, p
- Published
- 2021
- Full Text
- View/download PDF
16. LPS decreases CFTR open probability and mucociliary transport through generation of reactive oxygen species
- Author
-
Do Yeon Cho, Shaoyan Zhang, Ahmed Lazrak, Daniel Skinner, Harrison M. Thompson, Jessica Grayson, Purushotham Guroji, Saurabh Aggarwal, Zsuzsanna Bebok, Steven M. Rowe, Sadis Matalon, Eric J. Sorscher, and Bradford A. Woodworth
- Subjects
Lipopolysaccharide ,Cystic fibrosis transmembrane conductance regulator ,Reactive ,Oxygen species ,Mucociliary transport ,Micro optical coherence tomography ,Medicine (General) ,R5-920 ,Biology (General) ,QH301-705.5 - Abstract
Lipopolysaccharide (LPS) serves as the interface between gram-negative bacteria (GNB) and the innate immune response in respiratory epithelial cells (REC). Herein, we describe a novel biological role of LPS that permits GNB to persist in the respiratory tract through inducing CFTR and mucociliary dysfunction. LPS reduced cystic fibrosis transmembrane conductance regulater (CFTR)-mediated short-circuit current in mammalian REC in Ussing chambers and nearly abrogated CFTR single channel activity (defined as forskolin-activated Cl- currents) in patch clamp studies, effects of which were blocked with toll-like receptor (TLR)-4 inhibitor. Unitary conductance and single-channel amplitude of CFTR were unaffected, but open probability and number of active channels were markedly decreased. LPS increased cytoplasmic and mitochondrial reactive oxygen species resulting in CFTR carbonylation. All effects of exposure were eliminated when reduced glutathione was added in the medium along with LPS. Functional microanatomy parameters, including mucociliary transport, in human sinonasal epithelial cells in vitro were also decreased, but restored with co-incubation with glutathione or TLR-4 inhibitor. In vivo measurements, following application of LPS in the nasal cavities showed significant decreases in transepithelial Cl- secretion as measured by nasal potential difference (NPD) – an effect that was nullified with glutathione and TLR-4 inhibitor. These data provide definitive evidence that LPS-generated reactive intermediates downregulate CFTR function in vitro and in vivo which results in cystic fibrosis-type disease. Findings have implications for therapeutic approaches intent on stimulating Cl- secretion and/or reducing oxidative stress to decrease the sequelae of GNB airway colonization and infection.
- Published
- 2021
- Full Text
- View/download PDF
17. Geometry-Dependent Spectroscopic Contrast in Deep Tissues
- Author
-
Xin Ge, Hongying Tang, Xianghong Wang, Xinyu Liu, Si Chen, Nanshuo Wang, Guangming Ni, Xiaojun Yu, Shufen Chen, Haitao Liang, En Bo, Lulu Wang, Cilwyn Shalitha Braganza, Chenjie Xu, Steven M. Rowe, Guillermo J. Tearney, and Linbo Liu
- Subjects
Science - Abstract
Summary: Nano-structures of biological systems can produce diverse spectroscopic effects through interactions with broadband light. Although structured coloration at the surface has been extensively studied, natural spectroscopic contrasts in deep tissues are poorly understood, which may carry valuable information for evaluating the anatomy and function of biological systems. Here we investigated the spectroscopic characteristics of an important geometry in deep tissues at the nanometer scale: packed nano-cylinders, in the near-infrared window, numerically predicted and experimentally proved that transversely oriented and regularly arranged nano-cylinders could selectively backscatter light of the long wavelengths. Notably, we found that the spectroscopic contrast of nanoscale fibrous structures was sensitive to the pressure load, possibly owing to the changes in the orientation, the degree of alignment, and the spacing. To explore the underlying physical basis, we further developed an analytical model based on the radial distribution function in terms of their radius, refractive index, and spatial distribution. : Infrared Optics; Medical Imaging; Optical Imaging; Spectroscopy Subject Areas: Infrared Optics, Medical Imaging, Optical Imaging, Spectroscopy
- Published
- 2019
- Full Text
- View/download PDF
18. An Adeno-Associated Viral Vector Capable of Penetrating the Mucus Barrier to Inhaled Gene Therapy
- Author
-
Gregg A. Duncan, Namho Kim, Yanerys Colon-Cortes, Jason Rodriguez, Marina Mazur, Susan E. Birket, Steven M. Rowe, Natalie E. West, Alessandra Livraghi-Butrico, Richard C. Boucher, Justin Hanes, George Aslanidi, and Jung Soo Suk
- Subjects
Genetics ,QH426-470 ,Cytology ,QH573-671 - Abstract
Diffusion of the viral vectors evaluated in inhaled gene therapy clinical trials to date are largely hindered within airway mucus, which limits their access to, and transduction of, the underlying airway epithelium prior to clearance from the lung. Here, we discovered that adeno-associated virus (AAV) serotype 6 was able to rapidly diffuse through mucus collected from cystic fibrosis (CF) patients, unlike previously tested AAV serotypes. A point mutation of the AAV6 capsid suggests a potential mechanism by which AAV6 avoids adhesion to the mucus mesh. Significantly greater transgene expression was achieved with AAV6 compared to a mucoadhesive serotype, AAV1, in air-liquid interface cultures of human CF bronchial epithelium with naturally secreted mucus or induced mucus hypersecretion. In addition, AAV6 achieved superior distribution and overall level of transgene expression compared to AAV1 in the airways and whole lungs, respectively, of transgenic mice with airway mucus obstruction. Our findings motivate further evaluation and clinical development of AAV6 for inhaled gene therapy. Keywords: inhaled gene therapy, muco-obstructive lung disease, adeno-associated virus, airway mucus
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.